ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

University of Chicago at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

University of Chicago brings 12 presentations to ACR Convergence 2026 in Orlando. Its program centres on the rheumatic immune side effects of checkpoint inhibitor therapy, and on dermatomyositis, including interferon-targeted agents and brepocitinib. It also covers teaching about misinformation in rheumatology and cellular immunotherapy.

OrganizationACR Convergence 2026 Attendance
Universities and research institutes
A private research university with an academic medical center.
Session
Fri Nov 6
4:25pm–4:45pm
Part of FIT Program: Learning from the Expert: Rheumatology Roundtables
Rheumatic Immune-Related Adverse Events to ICI Therapy
W415D
Education and careers
Session
Fri Nov 6
4:45pm–5:05pm
Part of FIT Program: Learning from the Expert: Rheumatology Roundtables
Rheumatic Immune-Related Adverse Events to ICI Therapy
W415D
Education and careers
Session
Fri Nov 6
5:05pm–5:25pm
Part of FIT Program: Learning from the Expert: Rheumatology Roundtables
Rheumatic Immune-Related Adverse Events to ICI Therapy
W415D
Education and careers
Session
Fri Nov 6
5:25pm–5:45pm
Part of FIT Program: Learning from the Expert: Rheumatology Roundtables
Rheumatic Immune-Related Adverse Events to ICI Therapy
W415D
Education and careers
Talk
Sun Nov 8
10:00am–10:30am
Part of Precision Over Prednisone: Mechanism-Based Therapy for Dermatomyositis in the Modern Era
Novel Agents Targeting Interferon Signaling in Dermatomyositis
W304A-H
Myositis
Session
Sun Nov 8
4:00pm–5:00pm
Can You Beat the Board? Bring Your Toughest Rheumatic irAE Cases
W307C
Treatment safety
Session
Mon Nov 9
8:00am–9:30am
Distorted Signals: Teaching Misinformation and Disinformation in Rheumatology Across Diverse Populations
W205
Epidemiology and outcomes
  1. 8:00amDistorted Signals: Teaching Misinformation and Disinformation in Rheumatology Across Diverse Populations Panel DiscussionSMC Healthcare, TecSalud
Session
Tue Nov 10
1:00pm–2:30pm
Cellular Immunotherapy: Are we on the Cusp of a Therapeutic Revolution in Rheumatology? Session 3
Chapin Theater
Treatment safety · with University of Calgary, University of Washington
  1. 1:00pmPatients and Cellular Therapies: Organizing and Running Clinical Trials, and Where to Find themHospital for Special Surgery
  2. 1:20pmWhat's Happening in the Pediatric World of Cellular Therapy?Cincinnati Children's Hospital Medical Center
  3. 1:40pmFull Speed Ahead on Cellular Therapy in Rheumatology: ProFriedrich-Alexander-Universität Erlangen-Nürnberg
  4. 2:00pmFull Speed Ahead on Cellular Therapy in Rheumatology: ConBeth Israel Deaconess Medical Center

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Chicago

Tell us what you sell and we’ll find the people at University of Chicago most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction